Pyrimidinones as Casein Kinase II (CK2) Modulators
A compound having Formula (I) or a pharmaceutically acceptable salt thereof, wherein X, R1 and R2 are defined in the specification; pharmaceutical compositions thereof; and methods of use thereof.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | KIM MOON HWAN ARCALAS ARLYN KEARNEY PATRICK KENNEDY ABIGAIL R CHAN WAI KI VICKEY MANALO JEAN-CLAIRE LIMUN ANAND NEEL KUMAR ZHOU PEIWEN KOLTUN ELENA S BUSSENIUS JOERG DU HONGWANG TSANG TSZE H BLAZEY CHARLES M IBRAHIM MOHAMED ABDULKADER TSUHAKO AMY LEW RICE KENNETH D PETO CSABA J EPSHTEYN SERGEY |
| description | A compound having Formula (I) or a pharmaceutically acceptable salt thereof, wherein X, R1 and R2 are defined in the specification; pharmaceutical compositions thereof; and methods of use thereof. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2009215803A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2009215803A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2009215803A13</originalsourceid><addsrcrecordid>eNrjZDAKqCzKzM1MyczLz0stVkgsVnBOLE7NzFPwzswDMhQ8PRU0nL2NNBV881NKcxJL8ouKeRhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJfGiwkYGBpZGhqYWBsaOhMXGqANu0K4I</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Pyrimidinones as Casein Kinase II (CK2) Modulators</title><source>esp@cenet</source><creator>KIM MOON HWAN ; ARCALAS ARLYN ; KEARNEY PATRICK ; KENNEDY ABIGAIL R ; CHAN WAI KI VICKEY ; MANALO JEAN-CLAIRE LIMUN ; ANAND NEEL KUMAR ; ZHOU PEIWEN ; KOLTUN ELENA S ; BUSSENIUS JOERG ; DU HONGWANG ; TSANG TSZE H ; BLAZEY CHARLES M ; IBRAHIM MOHAMED ABDULKADER ; TSUHAKO AMY LEW ; RICE KENNETH D ; PETO CSABA J ; EPSHTEYN SERGEY</creator><creatorcontrib>KIM MOON HWAN ; ARCALAS ARLYN ; KEARNEY PATRICK ; KENNEDY ABIGAIL R ; CHAN WAI KI VICKEY ; MANALO JEAN-CLAIRE LIMUN ; ANAND NEEL KUMAR ; ZHOU PEIWEN ; KOLTUN ELENA S ; BUSSENIUS JOERG ; DU HONGWANG ; TSANG TSZE H ; BLAZEY CHARLES M ; IBRAHIM MOHAMED ABDULKADER ; TSUHAKO AMY LEW ; RICE KENNETH D ; PETO CSABA J ; EPSHTEYN SERGEY</creatorcontrib><description>A compound having Formula (I) or a pharmaceutically acceptable salt thereof, wherein X, R1 and R2 are defined in the specification; pharmaceutical compositions thereof; and methods of use thereof.</description><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090827&DB=EPODOC&CC=US&NR=2009215803A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090827&DB=EPODOC&CC=US&NR=2009215803A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KIM MOON HWAN</creatorcontrib><creatorcontrib>ARCALAS ARLYN</creatorcontrib><creatorcontrib>KEARNEY PATRICK</creatorcontrib><creatorcontrib>KENNEDY ABIGAIL R</creatorcontrib><creatorcontrib>CHAN WAI KI VICKEY</creatorcontrib><creatorcontrib>MANALO JEAN-CLAIRE LIMUN</creatorcontrib><creatorcontrib>ANAND NEEL KUMAR</creatorcontrib><creatorcontrib>ZHOU PEIWEN</creatorcontrib><creatorcontrib>KOLTUN ELENA S</creatorcontrib><creatorcontrib>BUSSENIUS JOERG</creatorcontrib><creatorcontrib>DU HONGWANG</creatorcontrib><creatorcontrib>TSANG TSZE H</creatorcontrib><creatorcontrib>BLAZEY CHARLES M</creatorcontrib><creatorcontrib>IBRAHIM MOHAMED ABDULKADER</creatorcontrib><creatorcontrib>TSUHAKO AMY LEW</creatorcontrib><creatorcontrib>RICE KENNETH D</creatorcontrib><creatorcontrib>PETO CSABA J</creatorcontrib><creatorcontrib>EPSHTEYN SERGEY</creatorcontrib><title>Pyrimidinones as Casein Kinase II (CK2) Modulators</title><description>A compound having Formula (I) or a pharmaceutically acceptable salt thereof, wherein X, R1 and R2 are defined in the specification; pharmaceutical compositions thereof; and methods of use thereof.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAKqCzKzM1MyczLz0stVkgsVnBOLE7NzFPwzswDMhQ8PRU0nL2NNBV881NKcxJL8ouKeRhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJfGiwkYGBpZGhqYWBsaOhMXGqANu0K4I</recordid><startdate>20090827</startdate><enddate>20090827</enddate><creator>KIM MOON HWAN</creator><creator>ARCALAS ARLYN</creator><creator>KEARNEY PATRICK</creator><creator>KENNEDY ABIGAIL R</creator><creator>CHAN WAI KI VICKEY</creator><creator>MANALO JEAN-CLAIRE LIMUN</creator><creator>ANAND NEEL KUMAR</creator><creator>ZHOU PEIWEN</creator><creator>KOLTUN ELENA S</creator><creator>BUSSENIUS JOERG</creator><creator>DU HONGWANG</creator><creator>TSANG TSZE H</creator><creator>BLAZEY CHARLES M</creator><creator>IBRAHIM MOHAMED ABDULKADER</creator><creator>TSUHAKO AMY LEW</creator><creator>RICE KENNETH D</creator><creator>PETO CSABA J</creator><creator>EPSHTEYN SERGEY</creator><scope>EVB</scope></search><sort><creationdate>20090827</creationdate><title>Pyrimidinones as Casein Kinase II (CK2) Modulators</title><author>KIM MOON HWAN ; ARCALAS ARLYN ; KEARNEY PATRICK ; KENNEDY ABIGAIL R ; CHAN WAI KI VICKEY ; MANALO JEAN-CLAIRE LIMUN ; ANAND NEEL KUMAR ; ZHOU PEIWEN ; KOLTUN ELENA S ; BUSSENIUS JOERG ; DU HONGWANG ; TSANG TSZE H ; BLAZEY CHARLES M ; IBRAHIM MOHAMED ABDULKADER ; TSUHAKO AMY LEW ; RICE KENNETH D ; PETO CSABA J ; EPSHTEYN SERGEY</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2009215803A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2009</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>KIM MOON HWAN</creatorcontrib><creatorcontrib>ARCALAS ARLYN</creatorcontrib><creatorcontrib>KEARNEY PATRICK</creatorcontrib><creatorcontrib>KENNEDY ABIGAIL R</creatorcontrib><creatorcontrib>CHAN WAI KI VICKEY</creatorcontrib><creatorcontrib>MANALO JEAN-CLAIRE LIMUN</creatorcontrib><creatorcontrib>ANAND NEEL KUMAR</creatorcontrib><creatorcontrib>ZHOU PEIWEN</creatorcontrib><creatorcontrib>KOLTUN ELENA S</creatorcontrib><creatorcontrib>BUSSENIUS JOERG</creatorcontrib><creatorcontrib>DU HONGWANG</creatorcontrib><creatorcontrib>TSANG TSZE H</creatorcontrib><creatorcontrib>BLAZEY CHARLES M</creatorcontrib><creatorcontrib>IBRAHIM MOHAMED ABDULKADER</creatorcontrib><creatorcontrib>TSUHAKO AMY LEW</creatorcontrib><creatorcontrib>RICE KENNETH D</creatorcontrib><creatorcontrib>PETO CSABA J</creatorcontrib><creatorcontrib>EPSHTEYN SERGEY</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KIM MOON HWAN</au><au>ARCALAS ARLYN</au><au>KEARNEY PATRICK</au><au>KENNEDY ABIGAIL R</au><au>CHAN WAI KI VICKEY</au><au>MANALO JEAN-CLAIRE LIMUN</au><au>ANAND NEEL KUMAR</au><au>ZHOU PEIWEN</au><au>KOLTUN ELENA S</au><au>BUSSENIUS JOERG</au><au>DU HONGWANG</au><au>TSANG TSZE H</au><au>BLAZEY CHARLES M</au><au>IBRAHIM MOHAMED ABDULKADER</au><au>TSUHAKO AMY LEW</au><au>RICE KENNETH D</au><au>PETO CSABA J</au><au>EPSHTEYN SERGEY</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Pyrimidinones as Casein Kinase II (CK2) Modulators</title><date>2009-08-27</date><risdate>2009</risdate><abstract>A compound having Formula (I) or a pharmaceutically acceptable salt thereof, wherein X, R1 and R2 are defined in the specification; pharmaceutical compositions thereof; and methods of use thereof.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2009215803A1 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
| title | Pyrimidinones as Casein Kinase II (CK2) Modulators |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T02%3A28%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KIM%20MOON%20HWAN&rft.date=2009-08-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2009215803A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |